-
Most Recent
Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Other industries you might be interested in
Recent Biotech Stocks Articles
Merck Could Have a Home Run in Sight
Merck’s new drug odanacatib can be thanked for the stock's recent rally, but there are two questions that need to be answered.
Investors Bag the Groceries: Thursday’s IP Market Recap
Markets were down as continued worries about Europe and another round of disappointing earnings and guidance pushed prices lower.
4 ETFs to Guard Against Market Volatility
Worried about the market's current uncertainty? A good defensive play right now is low-risk, low-beta ETFs. Here are four of the best.
Glaxo to Pay $3B in Fines for Improper Drug Marketing
GlaxoSmithKline will pay $3 billion in fines relating to its promotion of the antidepressant drugs, Paxil, Wellbutrin and Avandia, and the asthma drug Advair.
Should I Buy Bristol-Myers Squibb? 3 Pros, 3 Cons
Its deal to buy diabetes-drug maker Amylin will help, given that market's potential. Still, patent expirations loom large and won't be easily overcome.
What’s the Real Impact of Generic Drugs?
The danger of patent expirations for big pharma isn't new, but the amount of market share those brands are losing to generics as a result are not pretty.
3 Reasons to Flee Walgreen
The market is worried that Walgreen is still struggling to fill the right prescription at the right time. Here are three signs that spell trouble for WAG shares.
5 of Pharma’s Most Disastrous Drug Approvals
These five exciting drug approvals now serve as warning stories about the potential pitfalls for investors trying to time a pharma stock buy.
Wait on Arena’s Weight-Loss Drug
The FDA is all set to rule on Arena Pharmaceuticals' weight loss drug lorcaserin, and things look good, but its approval might already be priced in.
The Obamacare Ruling: 5 Investing Scenarios
The Supreme Court's looming decision will surely create winners and losers among health care stocks. Here's an investor's guide to the possible outcomes.
Don’t Buy Pharma Stocks — Buy THESE Pharma Stocks
If your sliver of the pharma pie is too small, it's easy to fall into the "any old pharma stock will do" trap. Keep your eye on the prize with these must-own names.
Time to Take Profits at Cerner
Cerner has been in our portfolio for a fairly short time but has performed extremely well. Now is a good time to lock in profits.
Pfizer to Spin Off Its Animal Health Biz
Pfizer announced Thursday its plan to spin off its animal health business into a stand-alone company named Zoetis.
Myriad Genetics Is a Biotech Buy
Myriad Technologies offers tests used to predetermine cancers and other diseases to provide pretreatment or prevention. Myriad is a biotech buy.
Genetic Testing a Chance to Profit From Prevention
Genetic testing and the sequencing of the gene is now 12 years old, and opportunities to profit through wise stock picks abound at this point.
A Steady Boat in Rough Biotech Waters
PDL BioPharma's (PDLI) isn't your everyday biopharmaceutical company -- it has a more predictable revenue stream, and even a substantial dividend payout.
